These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 25687380)

  • 1. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
    Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
    Slaby O
    Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
    Worm Ørntoft MB
    Clin Colorectal Cancer; 2018 Jun; 17(2):e415-e433. PubMed ID: 29678513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for early detection of colorectal cancer and polyps: systematic review.
    Shah R; Jones E; Vidart V; Kuppen PJ; Conti JA; Francis NK
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1712-28. PubMed ID: 25004920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.
    Dabbous HK; Mohamed YAE; El-Folly RF; El-Talkawy MD; Seddik HE; Johar D; Sarhan MA
    J Gastrointest Cancer; 2019 Sep; 50(3):442-450. PubMed ID: 29626277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening tests for colorectal cancer: a menu of options remains relevant.
    Allison JE; Lawson M
    Curr Oncol Rep; 2006 Nov; 8(6):492-8. PubMed ID: 17040627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The toll of not screening for colorectal cancer.
    Chen C; Hoffmeister M; Brenner H
    Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):1-3. PubMed ID: 27897033
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
    Ladabaum U; Allen J; Wandell M; Ramsey S
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
    Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial colorectal cancer screening: When and what to do?
    Del Vecchio Blanco G; Paoluzi OA; Sileri P; Rossi P; Sica G; Pallone F
    World J Gastroenterol; 2015 Jul; 21(26):7944-53. PubMed ID: 26185367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
    Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
    J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Overview of current modalities of colorectal cancer screening].
    Kajzrlíková IM; Vítek P
    Vnitr Lek; 2016 Apr; 62(4):308-11. PubMed ID: 27250609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
    Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
    Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in colorectal cancer screening.
    Pox CP
    Digestion; 2014; 89(4):274-81. PubMed ID: 25034478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review.
    Xue M; Lai SC; Xu ZP; Wang LJ
    J Dig Dis; 2015 Dec; 16(12):699-712. PubMed ID: 26565661
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.